Verywell Health on MSN18h
Causes of Ischemic Cardiomyopathy (ICM) and How to Treat It
Medically reviewed by Anisha Shah, MD Ischemia occurs when the heart does not receive adequate blood supply to function ...
The American Journal of Managed Care1d
American Heart Association to Celebrate 100th Year in Chicago, Where It All Began
Therapies for obesity and inhibitors for lipoprotein(a) (Lp[a]) are among those to be featured at the American Heart ...
Business Insider3d
Cytokinetics to Participate in the 2024 Jefferies London Healthcare Conference
Following positive results from SEQUOIA-HCM, the pivotal Phase 3 clinical trial evaluating aficamten, a next-in-class cardiac myosin inhibitor, in obstructive hypertrophic cardiomyopathy (HCM), ...
Cytokinetics: Strategic Growth and Strong Financial Positioning Drive Buy Rating
Analyst Roanna Ruiz of Leerink Partners maintained a Buy rating on Cytokinetics (CYTK – Research Report), reducing the price target to ...
ETF Daily News6d
LianBio (NASDAQ:LIAN) Stock Price Up 2.5% – Should You Buy?
The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with preserved ejection fraction; TP-03 for the treatment of Demodex ...